Journal
TISSUE ENGINEERING
Volume 13, Issue 8, Pages 1809-1823Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/ten.2006.0096
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL079419, HL083900, HL078534] Funding Source: Medline
Ask authors/readers for more resources
The field of cardiovascular tissue engineering has experienced tremendous advances in the past several decades, but the clinical reality of engineered heart tissue and vascular conduits remains immature. Stem cells and progenitor cells are promising cell sources for engineering functional cardiovascular tissues. To realize the therapeutic potential of stem cells and progenitor cells, we need to understand how micro-environmental cues modulate and guide stem cell differentiation and organization. This review describes the current understanding of the chemical and physical regulation of embryonic and adult stem cells for potential applications in cardiovascular repair, focusing on cardiac therapies after myocardial infarction and the engineering of vascular conduits.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available